Mesa Laboratories, Inc. Mesa Laboratories, Inc. Mesa Laboratories, Inc. Mesa Laboratories, Inc. Mesa Laboratories, Inc.
In this quarterly report on Form 10-Q, Mesa Laboratories, Inc., a Colorado corporation, together with its subsidiaries is collectively referred to as “we,” “us,” “our,” the “Company” or “Mesa.” We are organized into four divisions across eight physical locations.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission.
This quarterly report should be read in conjunction with the consolidated financial statements included in our annual report on Form 10-K for the year ended March 31, 2018.
We have initiated our plan for the adoption and implementation of this new accounting standard, including assessing our lease arrangements, evaluating practical expedients, and making necessary changes to our accounting policies, processes, and internal controls over financial reporting.
We expect to adopt the requirements of ASU 2016-02 beginning April 1, 2019 using the modified retrospective method.
The adoption did not have a material impact on our condensed consolidated balance sheets, statements of income, or cash flows.
In March 2018, the FASB issued ASU 2018-05, Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No.However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made.
We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
We pursue a strategy of focusing primarily on quality control products and services, which are sold into niche markets that are driven by regulatory requirements.
We are organized into four divisions across eight physical locations.
Our sterilization and disinfection control division (“SDC” Division) manufactures and sells biological, cleaning, and chemical indicators.
Our Instruments Division designs, manufactures, and markets quality control instruments and disposable products utilized in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries.
We typically evaluate costs and pricing annually.
Accordingly, it may vary with sales levels.Part II.